![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 413/04 | |
C07D 413/14 | |||
A61K 31/42 | |||
A61K 31/4245 | |||
A61K 31/44 | |||
A61P 3/00 |
(11) | Number of the document | 2205595 |
(13) | Kind of document | T |
(96) | European patent application number | 08804779.0 |
Date of filing the European patent application | 2008-09-26 | |
(97) | Date of publication of the European application | 2010-07-14 |
(45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2008/062900 |
Date | 2008-09-26 |
(87) | Number | WO 2009/040410 |
Date | 2009-04-02 |
(30) | Number | Date | Country code |
976064 P | 2007-09-28 | US |
(72) |
KWAK, Young-Shin, US
COPPOLA, Gary Mark, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |
OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |